Your browser doesn't support javascript.
loading
Conformational analysis of r207910, a new drug candidate for the treatment of tuberculosis, by a combined NMR and molecular modeling approach.
Gaurrand, Sandrine; Desjardins, Stéphanie; Meyer, Christophe; Bonnet, Pascal; Argoullon, Jean-Michel; Oulyadi, Hassan; Guillemont, Jérôme.
Affiliation
  • Gaurrand S; Johnson & Johnson Pharmaceutical Research & Development, Campus de Maigremont-BP615, 27106 Val de Reuil Cedex, France. sgaurran@prdfr.jnj.com
Chem Biol Drug Des ; 68(2): 77-84, 2006 Aug.
Article in En | MEDLINE | ID: mdl-16999772
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Magnetic Resonance Spectroscopy / Models, Molecular / Antitubercular Agents Type of study: Prognostic_studies Language: En Journal: Chem Biol Drug Des Journal subject: BIOQUIMICA / FARMACIA / FARMACOLOGIA Year: 2006 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Magnetic Resonance Spectroscopy / Models, Molecular / Antitubercular Agents Type of study: Prognostic_studies Language: En Journal: Chem Biol Drug Des Journal subject: BIOQUIMICA / FARMACIA / FARMACOLOGIA Year: 2006 Document type: Article Affiliation country: Country of publication: